Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 10 1997, 2663-2664, Vol 35, No. 10
E Julian, L Matas, V Ausina and M Luquin
A commercially available dot immunoassay that employs the lipoarabinomannan
antigen was evaluated for the serologic diagnosis of tuberculosis. The test
showed a high specificity (100%); however, its sensitivity was low (18.5%).
Antibodies to lipoarabinomannan were detected in the sera of 7 of 71
patients with newly acquired tuberculosis and in sera of 10 of 21 patients
with relapse tuberculosis. It has been shown by others that sera from
patients with relapse tuberculosis had a higher concentration of antibodies
and reacted with a greater variety of antigens (native culture filtrates of
Mycobacterium tuberculosis H37Rv) than did sera from patients with newly
acquired tuberculosis. Our data confirm the results of these previous
studies as far as lipoarabinomannan is concerned. We conclude that the
differences in the production of antibodies shown by the two groups of
tuberculous patients (new and relapse) must be taken into account when
assessing the usefulness of serologic tests for the diagnosis of
tuberculosis.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Detection of lipoarabinomannan antibodies in patients with newly acquired tuberculosis and patients with relapse tuberculosis
Departamento de Genetica y Microbiologia, Universidad Autonoma de Barcelona, Bellaterra, Spain.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»